RNF145 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.111000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.997600E-01
Normal-vs-Stage2
9.589200E-01
Normal-vs-Stage3
1.644630E-01
Normal-vs-Stage4
7.120800E-01
Stage1-vs-Stage2
1.918390E-01
Stage1-vs-Stage3
2.778300E-02
Stage1-vs-Stage4
6.075000E-01
Stage2-vs-Stage3
9.639800E-02
Stage2-vs-Stage4
6.524000E-01
Stage3-vs-Stage4
8.040000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.924200E-01
Normal-vs-AfricanAmerican
9.064800E-01
Normal-vs-Asian
6.519600E-01
Caucasian-vs-AfricanAmerican
6.812200E-01
Caucasian-vs-Asian
2.830200E-01
AfricanAmerican-vs-Asian
7.523400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.697000E-01
Normal-vs-Female
8.390600E-01
Male-vs-Female
4.820200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.612200E-01
Normal-vs-Age(41-60Yrs)
3.841000E-01
Normal-vs-Age(61-80Yrs)
8.612200E-01
Normal-vs-Age(81-100Yrs)
5.872200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.038800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.287000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.325800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.828100E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.879300E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.478200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.316800E-01
Normal-vs-Daily Drinker
8.181000E-01
Normal-vs-Weekly Drinker
6.446400E-01
Normal-vs-Occasional Drinker
4.679600E-01
Normal-vs-Social Drinker
4.613400E-01
Non Drinker-vs-Daily Drinker
3.462000E-01
Non Drinker-vs-Weekly Drinker
5.917800E-01
Non Drinker-vs-Occasional Drinker
1.303540E-02
Non Drinker-vs-Social Drinker
3.939300E-03
Daily Drinker-vs-Weekly Drinker
7.593600E-01
Daily Drinker-vs-Occasional Drinker
4.856300E-02
Daily Drinker-vs-Social Drinker
8.515500E-02
Weekly Drinker-vs-Occasional Drinker
3.866200E-02
Weekly Drinker-vs-Social Drinker
4.826200E-02
Occasional Drinker-vs-Social Drinker
5.964800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.318800E-01
Normal-vs-Grade 2
1.671820E-02
Normal-vs-Grade 3
7.100400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.784600E-01
Grade 1-vs-Grade 3
7.401600E-01
Grade 1-vs-Grade 4
2.318800E-01
Grade 2-vs-Grade 3
5.215600E-01
Grade 2-vs-Grade 4
1.671820E-02
Grade 3-vs-Grade 4
7.100400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.131600E-01
Normal-vs-NonDiabetic
9.320000E-01
Diabetic-vs-NonDiabetic
3.705200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.212000E-01
Normal-vs-NoPancreatitis
9.889600E-01
Pancreatitis-vs-NoPancreatitis
2.986400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.736800E-01
Normal-vs-N1
9.886400E-01
N0-vs-N1
2.655200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.636800E-01
Normal-vs-TP53-NonMutant
9.618200E-01
TP53-Mutant-vs-TP53-NonMutant
7.157600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
